Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q84149397)
Watch
English
Everolimus
scientific article published on 01 July 2009
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
title
Everolimus
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
author
Uma Yasothan
series ordinal
2
object named as
Uma Yasothan
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Peter Kirkpatrick
series ordinal
3
object named as
Peter Kirkpatrick
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
author name string
Michael B Atkins
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
publication date
1 July 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
published in
Nature Reviews Drug Discovery
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
volume
8
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
page(s)
535-536
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
issue
7
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
exact match
https://scigraph.springernature.com/pub.10.1038/nrd2924
0 references
cites work
Renal-Cell Carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD2924
retrieved
31 March 2020
Recent progress in the management of advanced renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD2924
retrieved
31 March 2020
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD2924
retrieved
31 March 2020
Current development of mTOR inhibitors as anticancer agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD2924
retrieved
31 March 2020
SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD2924
retrieved
31 March 2020
Chemical modification of rapamycin: the discovery of SDZ RAD.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD2924
retrieved
31 March 2020
mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD2924
retrieved
31 March 2020
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD2924
retrieved
31 March 2020
Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNRD2924
retrieved
31 March 2020
Identifiers
DOI
10.1038/NRD2924
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
PubMed ID
19568281
1 reference
stated in
Europe PubMed Central
PubMed ID
19568281
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568281%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit